Patient Diversity in Chinese Clinical Trials: Progress and Gaps
Patient Diversity in Chinese Clinical Trials: Progress and Gaps Improving Patient Diversity in Clinical Trials in China: Achievements and Challenges Introduction Patient diversity in clinical trials is critical to ensuring that therapies are safe and effective across different populations. In China, with its vast population of over 1.4 billion people and wide demographic variability, the…
Read More “Patient Diversity in Chinese Clinical Trials: Progress and Gaps” »